Avalo Therapeutics AVTX
NASDAQ AVTX
$8.51 +1.35 (+18.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Avalo Therapeutics (AVTX) Price to FCF (2017 - 2018)

Updated

Avalo Therapeutics' (AVTX) Price to FCF was 9.22 for Q2 2018, down 0.9% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Price to FCF (2017 - 2018) Analysis & Trends

For FY2017, Price to FCF at Avalo Therapeutics was 11.87.

  • Five-year quarterly Price to FCF spans a low of 4.26 in Q3 2017 and a high of 11.87 in Q4 2017.
  • Per Business Quant data, the three quarters before Q2 2018 came in at 9.30 (Q1 2018), 11.87 (Q4 2017) and 4.26 (Q3 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Avalo Therapeutics 386.09 Mn -587.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 2,211.75
Mar 31, 2018 2,231.17
Dec 31, 2017 2,845.85
Sep 30, 2017 1,021.08
API Access

Avalo Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=AVTX&period=max&api_key=YOUR_API_KEY